Page 33 - INSTITUTE FOR MEDICAL RESEARCH ANNUAL REPORT 2020
P. 33
IMR Annual Report 2020 17
Meeting with
Otorhinolaryngology
surgeons from Ministry of (CaRC) Cancer Research Centre
Health to discuss about
research on head and
neck cancers on the 25th
February 2020.
Laboratory diagnostic/services
Haematology and Stomatology Units provided many diagnostic tests in 2020 as detailed below.
Acute Myeloid Leukaemia (AML) Mutation Tests
AML Mutation Tests consists of identification of several prognostically important molecular
markers, including FLT3, NPM1, c-KIT and CEBPA. The status of AML mutation is important for risk
assessment and prognostication, as well as molecularly-based targeted therapy for treatment
decision though precision medicine.
TESTS PERFORMED UNDER AML MUTATION STUDY
300
256 256
250
191 191
200 178
137
150
101
100 81
50 30 31
0
FLT3-ITD FLT3-D835 NPM1 CEBPA c-KIT
2019 2020
